Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet-activating factor antagonism improves ventricular contractility in endotoxemia

M J Herbertson1, H A Werner, K R Walley

  • 1Pulmonary Research Laboratory, University of British Columbia, Vancouver, Canada.

Critical Care Medicine
|February 1, 1997
PubMed
Summary

Platelet-activating factor plays a modest role in sepsis-induced decreases in left ventricular contractility. Inhibiting this factor may improve cardiac function and hemodynamics during sepsis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute Kidney Injury and Renal Replacement Therapy in COVID-19 Versus Other Respiratory Viruses: A Systematic Review and Meta-Analysis.

Canadian journal of kidney health and disease·2021
Same author

Sepsis in pregnancy and the puerperium.

International journal of obstetric anesthesia·2018
Same author

Inpatient palliative care referral and 9-month hospital readmission in patients with congestive heart failure: a linked nationwide analysis.

Journal of internal medicine·2017
Same author

Two-year follow-up of patients with septic shock presenting with low HDL: the effect upon acute kidney injury, death and estimated glomerular filtration rate.

Journal of internal medicine·2017
Same author

PIERS proteinuria: relationship with adverse maternal and perinatal outcome.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2011
Same author

mRNA induces RANTES production in trophoblast cells via TLR3 only when delivered intracellularly using lipid membrane encapsulation.

Placenta·2011

Area of Science:

  • Cardiovascular Physiology
  • Sepsis Pathophysiology
  • Pharmacology

Background:

  • Endotoxins trigger platelet-activating factor (PAF) production, leading to decreased myocardial contractility in sepsis models.
  • PAF itself impairs left ventricular contractility.

Purpose of the Study:

  • To investigate the contribution of PAF to the reduction in left ventricular contractility observed during sepsis.

Main Methods:

  • A prospective, randomized, controlled animal study was conducted using 22 juvenile pigs.
  • Pigs received either a PAF receptor antagonist (L-659,989) or vehicle before endotoxin or saline administration.
  • Left ventricular contractility was assessed by measuring maximum elastance (Emax) via pressure-volume relationships.

Main Results:

Related Experiment Videos

  • Endotoxin administration decreased Emax by 41% and mean arterial pressure by 32% in control pigs.
  • In pigs pretreated with L-659,989, the decreases in Emax (26%) and mean arterial pressure (16%) were significantly attenuated.
  • These findings indicate a statistically significant protective effect of the PAF antagonist.

Conclusions:

  • Platelet-activating factor plays a significant, albeit modest, role in the early decline of left ventricular contractility following endotoxin exposure.
  • Inhibiting PAF during sepsis could offer therapeutic benefits for preserving cardiac mechanics and hemodynamics.